PBEInvesco Biotechnology & Genome ETF
Grow my money#1238 of 2944 for Grow my money
Seeks to track the investment results of the Dynamic Biotech & Genome Intellidex Index.
Invesco · Since 2005 (20 years)
Annual Cost
0.58%
#2732 out of 5,332 ETFs
Fund Size
$246M
#1956 out of 5,332 ETFs
Dividend Yield
1.09%
Track Record
20 years
#243 out of 5,332 ETFs
Performance
1 Year
+29.4%
3 Years
+9.6%
5 Years
+0.6%
What's inside
Asset class
Region
Focus
Biotech & Genomics
Asset allocation
Stocks
99.9%
Cash
0.1%
Sector breakdown
Healthcare
100.0%
Top holdings
United Therapeutics CorpUTHR6.5%
Illumina IncILMN5.2%
Regeneron Pharmaceuticals IncREGN5.2%
Alnylam Pharmaceuticals IncALNY5.2%
Gilead Sciences IncGILD4.9%
Biogen IncBIIB4.9%
Incyte CorpINCY4.9%
Amgen IncAMGN4.8%
BioCryst Pharmaceuticals IncBCRX3.6%
Protagonist Therapeutics IncPTGX3.4%
Risk profile
Volatility (1Y)
19.7%
Moderate
Max drawdown
-37.8%
Worst peak-to-trough loss
Sharpe (3Y)
0.38
Below average
Sortino (3Y)
0.55
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05